{
    "abstract": "This report covers the topics of pandemics, epidemics and partnerships, including regulatory convergence initiatives, new technologies and novel vaccines, discussed by leading public and private sector stakeholders at the 18th Annual General Meeting (AGM) of the Developing Countries Vaccine Manufacturers\u2019 Network (DCVMN). Contributions of Gavi and the vaccine industry from emerging countries to the growing global vaccine market, by improving the supply base from manufacturers in developing countries and contributing to 58% of doses, were highlighted. The Coalition for Epidemic Preparedness Innovations (CEPI), the International Vaccine Institute (IVI) and others reported on new strategies to ensure speedy progress in preclinical and clinical development of innovative vaccines for future MERS, Zika or other outbreak response. Priorities for vaccine stockpiling, to assure readiness during emergencies and to prevent outbreaks due to re-emerging diseases such as yellow fever, cholera and poliomyelitis, were outlined. The role of partnerships in improving global vaccine access, procurement and immunization coverage, and shared concerns were reviewed. The World Health Organization (WHO) and other international collaborating partners provided updates on the Product, Price and Procurement database, the prequalification of vaccines, the control of neglected tropical diseases, particularly the new rabies elimination initiative, and regulatory convergence proposals to accelerate vaccine registration in developing countries. Updates on supply chain innovations and novel vaccine platforms were presented. The discussions enabled members and partners to reflect on efficiency of research & development, supply chain tools and trends in packaging technologies improving delivery of existing vaccines, and allowing a deeper understanding of the current public-health objectives, industry financing, and global policies, required to ensure optimal investments, alignment and stability of vaccine supply in developing countries.",
    "bib_entries": {
        "b0005": null,
        "b0010": null,
        "b0015": {
            "authors": [
                {
                    "first": "Meghan L.",
                    "initial": "M.L.",
                    "last": "Stack"
                },
                {
                    "first": "Sachiko",
                    "initial": "S.",
                    "last": "Ozawa"
                },
                {
                    "first": "David M.",
                    "initial": "D.M.",
                    "last": "Bishai"
                },
                {
                    "first": "Andrew",
                    "initial": "A.",
                    "last": "Mirelman"
                },
                {
                    "first": "Yvonne",
                    "initial": "Y.",
                    "last": "Tam"
                },
                {
                    "first": "Louis",
                    "initial": "L.",
                    "last": "Niessen"
                },
                {
                    "first": "Damian G.",
                    "initial": "D.G.",
                    "last": "Walker"
                },
                {
                    "first": "Orin S.",
                    "initial": "O.S.",
                    "last": "Levine"
                }
            ],
            "doi": "10.1377/hlthaff.2011.0382",
            "firstpage": "1021",
            "issn": "02782715",
            "lastpage": "1028",
            "pmid": "21653952",
            "pub_year": 2011,
            "title": "Estimated economic benefits during the 'decade of vaccines' include treatment savings, gains in labor productivity",
            "volume": "30"
        },
        "b0020": {
            "authors": [
                {
                    "first": "Lisa A.",
                    "initial": "L.A.",
                    "last": "Lee"
                },
                {
                    "first": "Lauren",
                    "initial": "L.",
                    "last": "Franzel"
                },
                {
                    "first": "Jessica",
                    "initial": "J.",
                    "last": "Atwell"
                },
                {
                    "first": "S. Deblina",
                    "initial": "S.D.",
                    "last": "Datta"
                },
                {
                    "first": "Ingrid K.",
                    "initial": "I.K.",
                    "last": "Friberg"
                },
                {
                    "first": "Sue J.",
                    "initial": "S.J.",
                    "last": "Goldie"
                },
                {
                    "first": "Susan E.",
                    "initial": "S.E.",
                    "last": "Reef"
                },
                {
                    "first": "Nina",
                    "initial": "N.",
                    "last": "Schwalbe"
                },
                {
                    "first": "Emily",
                    "initial": "E.",
                    "last": "Simons"
                },
                {
                    "first": "Peter M.",
                    "initial": "P.M.",
                    "last": "Strebel"
                },
                {
                    "first": "Steven",
                    "initial": "S.",
                    "last": "Sweet"
                },
                {
                    "first": "Chutima",
                    "initial": "C.",
                    "last": "Suraratdecha"
                },
                {
                    "first": "Yvonne",
                    "initial": "Y.",
                    "last": "Tam"
                },
                {
                    "first": "Emilia",
                    "initial": "E.",
                    "last": "Vynnycky"
                },
                {
                    "first": "Neff",
                    "initial": "N.",
                    "last": "Walker"
                },
                {
                    "first": "Damian G.",
                    "initial": "D.G.",
                    "last": "Walker"
                },
                {
                    "first": "Peter M.",
                    "initial": "P.M.",
                    "last": "Hansen"
                }
            ],
            "doi": "10.1016/j.vaccine.2012.11.035",
            "firstpage": "B61",
            "issn": "0264410X",
            "lastpage": "B72",
            "pmid": "23598494",
            "pub_year": 2013,
            "title": "The estimated mortality impact of vaccinations forecast to be administered during 2011-2020 in 73 countries supported by the gavi alliance",
            "volume": "31"
        },
        "b0025": null,
        "b0030": null,
        "b0035": null,
        "b0040": null,
        "b0045": null,
        "b0050": null,
        "b0055": null,
        "b0060": {
            "authors": [
                {
                    "first": "Sheila",
                    "initial": "S.",
                    "last": "Isanaka"
                },
                {
                    "first": "Ousmane",
                    "initial": "O.",
                    "last": "Guindo"
                },
                {
                    "first": "Celine",
                    "initial": "C.",
                    "last": "Langendorf"
                },
                {
                    "first": "Amadou Matar",
                    "initial": "A.M.",
                    "last": "Seck"
                },
                {
                    "first": "Brian D.",
                    "initial": "B.D.",
                    "last": "Plikaytis"
                },
                {
                    "first": "Nathan",
                    "initial": "N.",
                    "last": "Sayinzoga-Makombe"
                },
                {
                    "first": "Monica M.",
                    "initial": "M.M.",
                    "last": "McNeal"
                },
                {
                    "first": "Nicole",
                    "initial": "N.",
                    "last": "Meyer"
                },
                {
                    "first": "Eric",
                    "initial": "E.",
                    "last": "Adehossi"
                },
                {
                    "first": "Ali",
                    "initial": "A.",
                    "last": "Djibo"
                },
                {
                    "first": "Bruno",
                    "initial": "B.",
                    "last": "Jochum"
                },
                {
                    "first": "Rebecca F.",
                    "initial": "R.F.",
                    "last": "Grais"
                }
            ],
            "doi": "10.1056/NEJMoa1609462",
            "firstpage": "1121",
            "issn": "00284793",
            "lastpage": "1130",
            "pmid": "28328346",
            "pub_year": 2017,
            "title": "Efficacy of a low-cost, heat-stable oral rotavirus vaccine in Niger",
            "volume": "376"
        },
        "b0065": null,
        "b0070": null,
        "b0075": null,
        "b0080": {
            "authors": [
                {
                    "first": "Sun Young",
                    "initial": "S.Y.",
                    "last": "Cho"
                },
                {
                    "first": "Ji Man",
                    "initial": "J.M.",
                    "last": "Kang"
                },
                {
                    "first": "Young Eun",
                    "initial": "Y.E.",
                    "last": "Ha"
                },
                {
                    "first": "Ga Eun",
                    "initial": "G.E.",
                    "last": "Park"
                },
                {
                    "first": "Ji Yeon",
                    "initial": "J.Y.",
                    "last": "Lee"
                },
                {
                    "first": "Jae Hoon",
                    "initial": "J.H.",
                    "last": "Ko"
                },
                {
                    "first": "Ji Yong",
                    "initial": "J.Y.",
                    "last": "Lee"
                },
                {
                    "first": "Jong Min",
                    "initial": "J.M.",
                    "last": "Kim"
                },
                {
                    "first": "Cheol In",
                    "initial": "C.I.",
                    "last": "Kang"
                },
                {
                    "first": "Ik Joon",
                    "initial": "I.J.",
                    "last": "Jo"
                },
                {
                    "first": "Jae Geum",
                    "initial": "J.G.",
                    "last": "Ryu"
                },
                {
                    "first": "Jong Rim",
                    "initial": "J.R.",
                    "last": "Choi"
                },
                {
                    "first": "Seonwoo",
                    "initial": "S.",
                    "last": "Kim"
                },
                {
                    "first": "Hee Jae",
                    "initial": "H.J.",
                    "last": "Huh"
                },
                {
                    "first": "Chang Seok",
                    "initial": "C.S.",
                    "last": "Ki"
                },
                {
                    "first": "Eun Suk",
                    "initial": "E.S.",
                    "last": "Kang"
                },
                {
                    "first": "Kyong Ran",
                    "initial": "K.R.",
                    "last": "Peck"
                },
                {
                    "first": "Hun Jong",
                    "initial": "H.J.",
                    "last": "Dhong"
                },
                {
                    "first": "Jae Hoon",
                    "initial": "J.H.",
                    "last": "Song"
                },
                {
                    "first": "Doo Ryeon",
                    "initial": "D.R.",
                    "last": "Chung"
                },
                {
                    "first": "Yae Jean",
                    "initial": "Y.J.",
                    "last": "Kim"
                }
            ],
            "doi": "10.1016/S0140-6736(16)30623-7",
            "firstpage": "994",
            "issn": "01406736",
            "lastpage": "1001",
            "pmid": "27402381",
            "pub_year": 2016,
            "title": "MERS-CoV outbreak following a single patient exposure in an emergency room in South Korea: an epidemiological outbreak study",
            "volume": "388"
        },
        "b0085": {
            "authors": [
                {
                    "first": "Emmie",
                    "initial": "E.",
                    "last": "De Wit"
                },
                {
                    "first": "Neeltje",
                    "initial": "N.",
                    "last": "Van Doremalen"
                },
                {
                    "first": "Darryl",
                    "initial": "D.",
                    "last": "Falzarano"
                },
                {
                    "first": "Vincent J.",
                    "initial": "V.J.",
                    "last": "Munster"
                }
            ],
            "doi": "10.1038/nrmicro.2016.81",
            "firstpage": "523",
            "issn": "17401526",
            "lastpage": "534",
            "pmid": "27344959",
            "pub_year": 2016,
            "title": "SARS and MERS: Recent insights into emerging coronaviruses",
            "volume": "14"
        },
        "b0090": {
            "authors": [
                {
                    "first": "Karuppiah",
                    "initial": "K.",
                    "last": "Muthumani"
                },
                {
                    "first": "Darryl",
                    "initial": "D.",
                    "last": "Falzarano"
                },
                {
                    "first": "Emma L.",
                    "initial": "E.L.",
                    "last": "Reuschel"
                },
                {
                    "first": "Colleen",
                    "initial": "C.",
                    "last": "Tingey"
                },
                {
                    "first": "Seleeke",
                    "initial": "S.",
                    "last": "Flingai"
                },
                {
                    "first": "Daniel O.",
                    "initial": "D.O.",
                    "last": "Villarreal"
                },
                {
                    "first": "Megan",
                    "initial": "M.",
                    "last": "Wise"
                },
                {
                    "first": "Ami",
                    "initial": "A.",
                    "last": "Patel"
                },
                {
                    "first": "Abdullah",
                    "initial": "A.",
                    "last": "Izmirly"
                },
                {
                    "first": "Abdulelah",
                    "initial": "A.",
                    "last": "Aljuaid"
                },
                {
                    "first": "Alecia M.",
                    "initial": "A.M.",
                    "last": "Seliga"
                },
                {
                    "first": "Geoff",
                    "initial": "G.",
                    "last": "Soule"
                },
                {
                    "first": "Matthew",
                    "initial": "M.",
                    "last": "Morrow"
                },
                {
                    "first": "Kimberly A.",
                    "initial": "K.A.",
                    "last": "Kraynyak"
                },
                {
                    "first": "Amir S.",
                    "initial": "A.S.",
                    "last": "Khan"
                },
                {
                    "first": "Dana P.",
                    "initial": "D.P.",
                    "last": "Scott"
                },
                {
                    "first": "Friederike",
                    "initial": "F.",
                    "last": "Feldmann"
                },
                {
                    "first": "Rachel",
                    "initial": "R.",
                    "last": "LaCasse"
                },
                {
                    "first": "Kimberly",
                    "initial": "K.",
                    "last": "Meade-White"
                },
                {
                    "first": "Atsushi",
                    "initial": "A.",
                    "last": "Okumura"
                },
                {
                    "first": "Kenneth E.",
                    "initial": "K.E.",
                    "last": "Ugen"
                },
                {
                    "first": "Niranjan Y.",
                    "initial": "N.Y.",
                    "last": "Sardesai"
                },
                {
                    "first": "J. Joseph",
                    "initial": "J.J.",
                    "last": "Kim"
                },
                {
                    "first": "Gary",
                    "initial": "G.",
                    "last": "Kobinger"
                },
                {
                    "first": "Heinz",
                    "initial": "H.",
                    "last": "Feldmann"
                },
                {
                    "first": "David B.",
                    "initial": "D.B.",
                    "last": "Weiner"
                }
            ],
            "doi": "10.1126/scitranslmed.aac7462",
            "issn": "19466234",
            "pmid": "26290414",
            "pub_year": 2015,
            "title": "A synthetic consensus anti-spike protein DNA vaccine induces protective immunity against Middle East respiratory syndrome coronavirus in nonhuman primates",
            "volume": "7"
        },
        "b0095": null,
        "b0100": null,
        "b0105": null,
        "b0110": null,
        "b0115": {
            "authors": [
                {
                    "first": "Bartholomew",
                    "initial": "B.",
                    "last": "Akanmori"
                },
                {
                    "first": "Ahmed",
                    "initial": "A.",
                    "last": "Bellah"
                },
                {
                    "first": "Mike",
                    "initial": "M.",
                    "last": "Ward"
                },
                {
                    "first": "Lembit",
                    "initial": "L.",
                    "last": "R\u00e4go"
                }
            ],
            "firstpage": "127",
            "issn": "10109609",
            "lastpage": "132",
            "pub_year": 2015,
            "title": "The African vaccine regulatory forum (AVAREF): A platform for collaboration in a public health emergency",
            "volume": "29"
        },
        "b0120": {
            "authors": [
                {
                    "first": "Diadi\u00e9",
                    "initial": "D.",
                    "last": "Ma\u00efga"
                },
                {
                    "first": "Bartholomew Dicky",
                    "initial": "B.D.",
                    "last": "Akanmori"
                },
                {
                    "first": "Liliana",
                    "initial": "L.",
                    "last": "Chocarro"
                }
            ],
            "doi": "10.1016/j.vaccine.2009.09.117",
            "firstpage": "571",
            "issn": "0264410X",
            "lastpage": "575",
            "pmid": "19833249",
            "pub_year": 2009,
            "title": "Joint reviews and inspections: Strategic forms of collaboration for strengthening the regulatory oversight of vaccine clinical trials in Africa",
            "volume": "28"
        },
        "b0125": null,
        "b0130": null,
        "b0135": null,
        "b0140": null,
        "b0145": null,
        "b0150": null,
        "b0155": {
            "authors": [
                {
                    "first": "Sudeep",
                    "initial": "S.",
                    "last": "Kothari"
                },
                {
                    "first": "Neha",
                    "initial": "N.",
                    "last": "Kothari"
                },
                {
                    "first": "Jeong Ah",
                    "initial": "J.A.",
                    "last": "Kim"
                },
                {
                    "first": "Eugene",
                    "initial": "E.",
                    "last": "Lee"
                },
                {
                    "first": "Yeon Kyung",
                    "initial": "Y.K.",
                    "last": "Yoon"
                },
                {
                    "first": "So Jung",
                    "initial": "S.J.",
                    "last": "An"
                },
                {
                    "first": "Christopher",
                    "initial": "C.",
                    "last": "Jones"
                },
                {
                    "first": "Woo Seok",
                    "initial": "W.S.",
                    "last": "Choe"
                },
                {
                    "first": "Rodney",
                    "initial": "R.",
                    "last": "Carbis"
                }
            ],
            "doi": "10.1016/j.vaccine.2013.08.037",
            "firstpage": "4714",
            "issn": "0264410X",
            "lastpage": "4719",
            "pmid": "23994374",
            "pub_year": 2013,
            "title": "A novel method for purification of Vi capsular polysaccharide produced by Salmonella enterica subspecies enterica serovar Typhi",
            "volume": "31"
        },
        "b0160": {
            "authors": [
                {
                    "first": "Karen M.",
                    "initial": "K.M.",
                    "last": "Edmond"
                },
                {
                    "first": "Christina",
                    "initial": "C.",
                    "last": "Kortsalioudaki"
                },
                {
                    "first": "Susana",
                    "initial": "S.",
                    "last": "Scott"
                },
                {
                    "first": "Stephanie J.",
                    "initial": "S.J.",
                    "last": "Schrag"
                },
                {
                    "first": "Anita Km",
                    "initial": "A.K.",
                    "last": "Zaidi"
                },
                {
                    "first": "Simon",
                    "initial": "S.",
                    "last": "Cousens"
                },
                {
                    "first": "Paul T.",
                    "initial": "P.T.",
                    "last": "Heath"
                }
            ],
            "doi": "10.1016/S0140-6736(11)61651-6",
            "firstpage": "547",
            "issn": "01406736",
            "lastpage": "556",
            "pmid": "22226047",
            "pub_year": 2012,
            "title": "Group B streptococcal disease in infants aged younger than 3 months: Systematic review and meta-analysis",
            "volume": "379"
        },
        "b0165": null,
        "b0170": {
            "authors": [
                {
                    "first": "Sameer P.",
                    "initial": "S.P.",
                    "last": "Naik"
                },
                {
                    "first": "Jagdish K.",
                    "initial": "J.K.",
                    "last": "Zade"
                },
                {
                    "first": "Rajendra N.",
                    "initial": "R.N.",
                    "last": "Sabale"
                },
                {
                    "first": "Sambhaji S.",
                    "initial": "S.S.",
                    "last": "Pisal"
                },
                {
                    "first": "Ravi",
                    "initial": "R.",
                    "last": "Menon"
                },
                {
                    "first": "Subhash G.",
                    "initial": "S.G.",
                    "last": "Bankar"
                },
                {
                    "first": "Sunil",
                    "initial": "S.",
                    "last": "Gairola"
                },
                {
                    "first": "Rajeev M.",
                    "initial": "R.M.",
                    "last": "Dhere"
                }
            ],
            "doi": "10.1016/j.vaccine.2017.04.025",
            "firstpage": "2962",
            "issn": "0264410X",
            "lastpage": "2969",
            "pmid": "28434688",
            "pub_year": 2017,
            "title": "Stability of heat stable, live attenuated Rotavirus vaccine (ROTASIIL\u00ae)",
            "volume": "35"
        },
        "b0175": {
            "authors": [
                {
                    "first": "Yeong Ok",
                    "initial": "Y.O.",
                    "last": "Baik"
                },
                {
                    "first": "Seuk Keun",
                    "initial": "S.K.",
                    "last": "Choi"
                },
                {
                    "first": "Remigio M.",
                    "initial": "R.M.",
                    "last": "Olveda"
                },
                {
                    "first": "Roberto A.",
                    "initial": "R.A.",
                    "last": "Espos"
                },
                {
                    "first": "Antonio D.",
                    "initial": "A.D.",
                    "last": "Ligsay"
                },
                {
                    "first": "May B.",
                    "initial": "M.B.",
                    "last": "Montellano"
                },
                {
                    "first": "Jong Sun",
                    "initial": "J.S.",
                    "last": "Yeam"
                },
                {
                    "first": "Jae Seung",
                    "initial": "J.S.",
                    "last": "Yang"
                },
                {
                    "first": "Ju Yeon",
                    "initial": "J.Y.",
                    "last": "Park"
                },
                {
                    "first": "Deok Ryun",
                    "initial": "D.R.",
                    "last": "Kim"
                },
                {
                    "first": "Sachin N.",
                    "initial": "S.N.",
                    "last": "Desai"
                },
                {
                    "first": "Ajit Pal",
                    "initial": "A.P.",
                    "last": "Singh"
                },
                {
                    "first": "Ick Young",
                    "initial": "I.Y.",
                    "last": "Kim"
                },
                {
                    "first": "Chan Wha",
                    "initial": "C.W.",
                    "last": "Kim"
                },
                {
                    "first": "Sue Nie",
                    "initial": "S.N.",
                    "last": "Park"
                }
            ],
            "doi": "10.1016/j.vaccine.2015.08.075",
            "firstpage": "6360",
            "issn": "0264410X",
            "lastpage": "6365",
            "pmid": "26348402",
            "pub_year": 2015,
            "title": "A randomized, non-inferiority trial comparing two bivalent killed, whole cell, oral cholera vaccines (Euvichol vs Shanchol) in the Philippines",
            "volume": "33"
        },
        "b0180": {
            "authors": [
                {
                    "first": "Alexander J.",
                    "initial": "A.J.",
                    "last": "Millman"
                },
                {
                    "first": "Fiona",
                    "initial": "F.",
                    "last": "Havers"
                },
                {
                    "first": "A. Danielle",
                    "initial": "A.D.",
                    "last": "Iuliano"
                },
                {
                    "first": "C. Todd",
                    "initial": "C.T.",
                    "last": "Davis"
                },
                {
                    "first": "Borann",
                    "initial": "B.",
                    "last": "Sar"
                },
                {
                    "first": "Ly",
                    "initial": "L.",
                    "last": "Sovann"
                },
                {
                    "first": "Savuth",
                    "initial": "S.",
                    "last": "Chin"
                },
                {
                    "first": "Andrew L.",
                    "initial": "A.L.",
                    "last": "Corwin"
                },
                {
                    "first": "Phengta",
                    "initial": "P.",
                    "last": "Vongphrachanh"
                },
                {
                    "first": "Bounlom",
                    "initial": "B.",
                    "last": "Douangngeun"
                },
                {
                    "first": "Kim A.",
                    "initial": "K.A.",
                    "last": "Lindblade"
                },
                {
                    "first": "Malinee",
                    "initial": "M.",
                    "last": "Chittaganpitch"
                },
                {
                    "first": "Viriya",
                    "initial": "V.",
                    "last": "Kaewthong"
                },
                {
                    "first": "James C.",
                    "initial": "J.C.",
                    "last": "Kile"
                },
                {
                    "first": "Hien T.",
                    "initial": "H.T.",
                    "last": "Nguyen"
                },
                {
                    "first": "Dong V.",
                    "initial": "D.V.",
                    "last": "Pham"
                },
                {
                    "first": "Ruben O.",
                    "initial": "R.O.",
                    "last": "Donis"
                },
                {
                    "first": "Marc Alain",
                    "initial": "M.A.",
                    "last": "Widdowson"
                }
            ],
            "doi": "10.3201/eid2105.141756",
            "firstpage": "741",
            "issn": "10806040",
            "lastpage": "749",
            "pmid": "25897654",
            "pub_year": 2015,
            "title": "Detecting spread of avian influenza A(H7N9) virus beyond China",
            "volume": "21"
        },
        "b0185": {
            "authors": [
                {
                    "first": "James C.",
                    "initial": "J.C.",
                    "last": "Kile"
                },
                {
                    "first": "Ruiqi",
                    "initial": "R.",
                    "last": "Ren"
                },
                {
                    "first": "Liqi",
                    "initial": "L.",
                    "last": "Liu"
                },
                {
                    "first": "Carolyn M.",
                    "initial": "C.M.",
                    "last": "Greene"
                },
                {
                    "first": "Katherine",
                    "initial": "K.",
                    "last": "Roguski"
                },
                {
                    "first": "A.",
                    "initial": "A.",
                    "last": "Danielle Iuliano"
                },
                {
                    "first": "Yunho",
                    "initial": "Y.",
                    "last": "Jang"
                },
                {
                    "first": "Joyce",
                    "initial": "J.",
                    "last": "Jones"
                },
                {
                    "first": "Sharmi",
                    "initial": "S.",
                    "last": "Thor"
                },
                {
                    "first": "Ying",
                    "initial": "Y.",
                    "last": "Song"
                },
                {
                    "first": "Suizan",
                    "initial": "S.",
                    "last": "Zhou"
                },
                {
                    "first": "Susan C.",
                    "initial": "S.C.",
                    "last": "Trock"
                },
                {
                    "first": "Vivien",
                    "initial": "V.",
                    "last": "Dugan"
                },
                {
                    "first": "David E.",
                    "initial": "D.E.",
                    "last": "Wentworth"
                },
                {
                    "first": "Min Z.",
                    "initial": "M.Z.",
                    "last": "Levine"
                },
                {
                    "first": "Timothy M.",
                    "initial": "T.M.",
                    "last": "Uyeki"
                },
                {
                    "first": "Jacqueline M.",
                    "initial": "J.M.",
                    "last": "Katz"
                },
                {
                    "first": "Daniel B.",
                    "initial": "D.B.",
                    "last": "Jernigan"
                },
                {
                    "first": "Sonja J.",
                    "initial": "S.J.",
                    "last": "Olsen"
                },
                {
                    "first": "Alicia M.",
                    "initial": "A.M.",
                    "last": "Fry"
                },
                {
                    "first": "Eduardo",
                    "initial": "E.",
                    "last": "Azziz-Baumgartner"
                },
                {
                    "first": "C.",
                    "initial": "C.",
                    "last": "Todd Davis"
                }
            ],
            "doi": "10.15585/mmwr.mm6635a2",
            "firstpage": "928",
            "issn": "01492195",
            "lastpage": "932",
            "pmid": "28880856",
            "pub_year": 2017,
            "title": "Update: Increase in human infections with novel Asian lineage avian influenza a(h7n9) viruses during the fifth epidemic - China, October 1, 2016-August 7, 2017",
            "volume": "66"
        },
        "b0190": {
            "authors": [
                {
                    "first": "Un In",
                    "initial": "U.I.",
                    "last": "Wu"
                },
                {
                    "first": "Szu Min",
                    "initial": "S.M.",
                    "last": "Hsieh"
                },
                {
                    "first": "Wen Sen",
                    "initial": "W.S.",
                    "last": "Lee"
                },
                {
                    "first": "Ning Chi",
                    "initial": "N.C.",
                    "last": "Wang"
                },
                {
                    "first": "Hsiang Chi",
                    "initial": "H.C.",
                    "last": "Kung"
                },
                {
                    "first": "Tsong Yih",
                    "initial": "T.Y.",
                    "last": "Ou"
                },
                {
                    "first": "Fu Lun",
                    "initial": "F.L.",
                    "last": "Chen"
                },
                {
                    "first": "Te Yu",
                    "initial": "T.Y.",
                    "last": "Lin"
                },
                {
                    "first": "Yee Chun",
                    "initial": "Y.C.",
                    "last": "Chen"
                },
                {
                    "first": "Shan Chwen",
                    "initial": "S.C.",
                    "last": "Chang"
                }
            ],
            "doi": "10.1016/j.vaccine.2017.06.044",
            "firstpage": "4099",
            "issn": "0264410X",
            "lastpage": "4104",
            "pmid": "28668573",
            "pub_year": 2017,
            "title": "Safety and immunogenicity of an inactivated cell culture-derived H7N9 influenza vaccine in healthy adults: A phase I/II, prospective, randomized, open-label trial",
            "volume": "35"
        },
        "b0195": {
            "authors": [
                {
                    "first": "Robert L.",
                    "initial": "R.L.",
                    "last": "Burton"
                },
                {
                    "first": "Moon H.",
                    "initial": "M.H.",
                    "last": "Nahm"
                }
            ],
            "doi": "10.1128/CVI.00112-06",
            "firstpage": "1004",
            "issn": "15566811",
            "lastpage": "1009",
            "pmid": "16960111",
            "pub_year": 2006,
            "title": "Development and validation of a fourfold multiplexed opsonization assay (MOPA4) for pneumococcal antibodies",
            "volume": "13"
        },
        "b0200": {
            "authors": [
                {
                    "first": "R. L.",
                    "initial": "R.L.",
                    "last": "Burton"
                },
                {
                    "first": "J.",
                    "initial": "J.",
                    "last": "Antonello"
                },
                {
                    "first": "D.",
                    "initial": "D.",
                    "last": "Cooper"
                },
                {
                    "first": "D.",
                    "initial": "D.",
                    "last": "Goldblatt"
                },
                {
                    "first": "K. H.",
                    "initial": "K.H.",
                    "last": "Kim"
                },
                {
                    "first": "B. D.",
                    "initial": "B.D.",
                    "last": "Plikaytis"
                },
                {
                    "first": "L.",
                    "initial": "L.",
                    "last": "Roalfe"
                },
                {
                    "first": "D.",
                    "initial": "D.",
                    "last": "Wauters"
                },
                {
                    "first": "F.",
                    "initial": "F.",
                    "last": "Williams"
                },
                {
                    "first": "G. L.",
                    "initial": "G.L.",
                    "last": "Xie"
                },
                {
                    "first": "M. H.",
                    "initial": "M.H.",
                    "last": "Nahm"
                },
                {
                    "first": "M.",
                    "initial": "M.",
                    "last": "Akkoyunlu"
                }
            ],
            "doi": "10.1128/CVI.00457-16",
            "issn": "15566811",
            "pmid": "27974397",
            "pub_year": 2017,
            "title": "Assignment of opsonic values to pneumococcal reference serum 007sp for use in opsonophagocytic assays for 13 serotypes",
            "volume": "24"
        },
        "b0205": {
            "authors": [
                {
                    "first": "Ursula",
                    "initial": "U.",
                    "last": "Hainz"
                },
                {
                    "first": "Brigitte",
                    "initial": "B.",
                    "last": "Jenewein"
                },
                {
                    "first": "Esther",
                    "initial": "E.",
                    "last": "Asch"
                },
                {
                    "first": "Karl P.",
                    "initial": "K.P.",
                    "last": "Pfeiffer"
                },
                {
                    "first": "Peter",
                    "initial": "P.",
                    "last": "Berger"
                },
                {
                    "first": "Beatrix",
                    "initial": "B.",
                    "last": "Grubeck-Loebenstein"
                }
            ],
            "doi": "10.1016/j.vaccine.2005.01.085",
            "firstpage": "3232",
            "issn": "0264410X",
            "lastpage": "3235",
            "pmid": "15837226",
            "pub_year": 2005,
            "title": "Insufficient protection for healthy elderly adults by tetanus and TBE vaccines",
            "volume": "23"
        },
        "b0210": {
            "authors": [
                {
                    "first": "Keith",
                    "initial": "K.",
                    "last": "Naylor"
                },
                {
                    "first": "Guangjin",
                    "initial": "G.",
                    "last": "Li"
                },
                {
                    "first": "Abbe N.",
                    "initial": "A.N.",
                    "last": "Vallelo"
                },
                {
                    "first": "Won Woo",
                    "initial": "W.W.",
                    "last": "Lee"
                },
                {
                    "first": "Kerstin",
                    "initial": "K.",
                    "last": "Koetz"
                },
                {
                    "first": "Ewa",
                    "initial": "E.",
                    "last": "Bryl"
                },
                {
                    "first": "Jacek",
                    "initial": "J.",
                    "last": "Witkowski"
                },
                {
                    "first": "James",
                    "initial": "J.",
                    "last": "Fulbright"
                },
                {
                    "first": "Cornelia M.",
                    "initial": "C.M.",
                    "last": "Weyand"
                },
                {
                    "first": "J\u00f6rg J.",
                    "initial": "J.J.",
                    "last": "Goronzy"
                }
            ],
            "doi": "10.4049/jimmunol.174.11.7446",
            "firstpage": "7446",
            "issn": "00221767",
            "lastpage": "7452",
            "pmid": "15905594",
            "pub_year": 2005,
            "title": "The influence of age on T cell generation and TCR diversity",
            "volume": "174"
        },
        "b0215": {
            "authors": [
                {
                    "first": "Marie R.",
                    "initial": "M.R.",
                    "last": "Griffin"
                },
                {
                    "first": "Yuwei",
                    "initial": "Y.",
                    "last": "Zhu"
                },
                {
                    "first": "Matthew R.",
                    "initial": "M.R.",
                    "last": "Moore"
                },
                {
                    "first": "Cynthia G.",
                    "initial": "C.G.",
                    "last": "Whitney"
                },
                {
                    "first": "Carlos G.",
                    "initial": "C.G.",
                    "last": "Grijalva"
                }
            ],
            "doi": "10.1056/NEJMoa1209165",
            "firstpage": "155",
            "issn": "00284793",
            "lastpage": "163",
            "pub_year": 2013,
            "title": "U.S. hospitalizations for pneumonia after a decade of pneumococcal vaccination",
            "volume": "369"
        },
        "b0220": null
    },
    "body_text": [
        {
            "endOffset": 22412,
            "parents": [],
            "secId": "s0010",
            "sentence": "S. Zipursky updated the audience on the WHO-Polio Endgame, as wild poliovirus continued to be transmitted in Pakistan and Afghanistan in 2017, and six vaccine-derived poliovirus type 2 (VDPV2) outbreaks were recorded in Syria, Pakistan, Nigeria and the Democratic Republic of Congo.",
            "startOffset": 22130,
            "title": "Vaccine procurement and financing"
        },
        {
            "endOffset": 27672,
            "parents": [],
            "secId": "s0015",
            "sentence": "A discussion on epidemic and pandemic preparedness was moderated by M. Friede from WHO.",
            "startOffset": 27585,
            "title": "Epidemic and pandemic vaccines"
        },
        {
            "endOffset": 28680,
            "parents": [],
            "secId": "s0015",
            "sentence": "R. Hatchett noted that CEPI is developing agreements with companies to support vaccines\u2019 manufacturing against diseases with epidemic potential, particularly if there is no routine market for such vaccines.",
            "startOffset": 28474,
            "title": "Epidemic and pandemic vaccines"
        },
        {
            "endOffset": 30301,
            "parents": [],
            "secId": "s0020",
            "sentence": "A. Oswald, BGMF, noted that there are over 100 vaccine manufacturers, which raises strategic questions on how they will compete, and how to balance value and access through partnerships.",
            "startOffset": 30115,
            "title": "Innovative partnerships"
        },
        {
            "endOffset": 35217,
            "parents": [],
            "refoffsets": {
                "b0125": {
                    "endOffset": 35216,
                    "startOffset": 35212
                }
            },
            "secId": "s0030",
            "sentence": "C. Rodriguez reviewed the WHO prequalification process, the programmatic suitability for prequalification (PSPQ) of vaccines and the activities following prequalification of a vaccine [25].",
            "startOffset": 35028,
            "title": "WHO prequalification updates"
        },
        {
            "endOffset": 33345,
            "parents": [],
            "secId": "s0025",
            "sentence": "Better alignment of the Common Technical Document (CTD) numbering and content, a standardized model-application form and convergence of evaluation procedures, including reliance on WHO prequalification, would improve registration efficiency.",
            "startOffset": 33104,
            "title": "Regulatory convergence initiatives"
        },
        {
            "endOffset": 23602,
            "parents": [],
            "refoffsets": {
                "b0050": {
                    "endOffset": 23601,
                    "startOffset": 23594
                },
                "b0055": {
                    "endOffset": 23601,
                    "startOffset": 23594
                }
            },
            "secId": "s0010",
            "sentence": "MSF contributed to overcoming intellectual property and registration barriers and challenged high costs of vaccines where they constitute a barrier to access [10,11].",
            "startOffset": 23436,
            "title": "Vaccine procurement and financing"
        },
        {
            "endOffset": 36024,
            "parents": [],
            "refoffsets": {
                "b0105": {
                    "endOffset": 35918,
                    "startOffset": 35914
                }
            },
            "secId": "s0030",
            "sentence": "Outcomes included expedited review of clinical trials during emergencies, setup of the pre-EUAL process and database [21], strengthening decision-making capacity during emergency responses, and surveillance system improvements.",
            "startOffset": 35797,
            "title": "WHO prequalification updates"
        },
        {
            "endOffset": 41550,
            "parents": [],
            "refoffsets": {
                "b0160": {
                    "endOffset": 41548,
                    "startOffset": 41541
                },
                "b0165": {
                    "endOffset": 41548,
                    "startOffset": 41541
                }
            },
            "secId": "s0040",
            "sentence": "P. Tippoo described Biovac\u2019s development, with PATH, of a novel vaccine against GBS, a leading cause of sepsis and meningitis in neonates and young infants, and found in a high proportion of pregnant women (10\u201340%, [32,33]).",
            "startOffset": 41326,
            "title": "Novel vaccines and technology platforms"
        },
        {
            "endOffset": 42919,
            "parents": [],
            "secId": "s0040",
            "sentence": "This presentation reduces package volume by 30% and shipping weight by over 50%, improving storage, transportation and waste management.",
            "startOffset": 42783,
            "title": "Novel vaccines and technology platforms"
        },
        {
            "endOffset": 34313,
            "parents": [],
            "secId": "s0025",
            "sentence": "R. Hatchett agreed that well-informed regulators will be better equipped to anticipate needs and evaluate counter-measures.",
            "startOffset": 34190,
            "title": "Regulatory convergence initiatives"
        },
        {
            "endOffset": 44580,
            "parents": [],
            "refoffsets": {
                "b0195": {
                    "endOffset": 44579,
                    "startOffset": 44575
                }
            },
            "secId": "s0040",
            "sentence": "Immunogenicity is measured by the quantitative ELISA or an opsonophagocytosis assay (OPA), measuring protective function [39].",
            "startOffset": 44454,
            "title": "Novel vaccines and technology platforms"
        },
        {
            "endOffset": 24709,
            "parents": [],
            "secId": "s0010",
            "sentence": "A. Oswald, from BMGF,4 recommended balance between affordable vaccines and viable manufacturers investing in large-scale and innovative products, by following each objective separately.",
            "startOffset": 24465,
            "title": "Vaccine procurement and financing"
        },
        {
            "endOffset": 38704,
            "parents": [],
            "refoffsets": {
                "b0140": {
                    "endOffset": 38703,
                    "startOffset": 38699
                }
            },
            "secId": "s0035",
            "sentence": "Four established VVM categories are available for vaccines: VVM2, 7, 14 and 30 [28].",
            "startOffset": 38620,
            "title": "Innovative solutions for vaccine supply and distribution"
        },
        {
            "endOffset": 23338,
            "parents": [],
            "secId": "s0010",
            "sentence": "E. Torreele reported that M\u00e9decins sans Fronti\u00e8res (MSF) administered over 5 million vaccine doses in over 30 countries in 2015.",
            "startOffset": 23210,
            "title": "Vaccine procurement and financing"
        },
        {
            "endOffset": 42255,
            "parents": [],
            "secId": "s0040",
            "sentence": "A single-dose, plastic vial presentation is expected to be available by the end of 2018.",
            "startOffset": 42167,
            "title": "Novel vaccines and technology platforms"
        },
        {
            "endOffset": 19466,
            "parents": [],
            "secId": "s0005",
            "sentence": "Gavi\u2019s role in outbreak preparedness and response is also growing through maintaining stockpiles of yellow fever, measles and cholera vaccines and investing in additional key vaccines, such as Ebola.",
            "startOffset": 19267,
            "title": "Introduction"
        },
        {
            "endOffset": 27813,
            "parents": [],
            "secId": "s0015",
            "sentence": "O. Leroy highlighted that global leadership and dialogue is needed to establish coordinated strategy and harmonized regulatory requirements.",
            "startOffset": 27673,
            "title": "Epidemic and pandemic vaccines"
        },
        {
            "endOffset": 33103,
            "parents": [],
            "secId": "s0025",
            "sentence": "Application forms of eight countries and registration procedures of 134 importing countries were compared, revealing divergence in requirements.",
            "startOffset": 32959,
            "title": "Regulatory convergence initiatives"
        },
        {
            "endOffset": 32156,
            "parents": [],
            "secId": "s0025",
            "sentence": "Guidance documents are being prepared for nucleic acid, hepatitis E, meningitis B and enterovirus vaccines.",
            "startOffset": 32049,
            "title": "Regulatory convergence initiatives"
        },
        {
            "endOffset": 32335,
            "parents": [],
            "secId": "s0025",
            "sentence": "To overcome registration delays, avoid duplication of efforts and advance access to vaccines, a collaborative procedure and joint dossier review committees are being implemented.",
            "startOffset": 32157,
            "title": "Regulatory convergence initiatives"
        },
        {
            "endOffset": 37631,
            "parents": [],
            "secId": "s0035",
            "sentence": "Stevanato Group has glass cartridge and ampoule designs.",
            "startOffset": 37575,
            "title": "Innovative solutions for vaccine supply and distribution"
        },
        {
            "endOffset": 45179,
            "parents": [],
            "secId": "s0045",
            "sentence": "Needs for additional innovative human vaccines, from birth to old age, were highlighted (Table 1).",
            "startOffset": 45081,
            "title": "Conclusion: The life cycle and global opportunities"
        },
        {
            "endOffset": 40557,
            "parents": [],
            "secId": "s0040",
            "sentence": "Upstream improvements included use of fed-batch culture and optimized media.",
            "startOffset": 40481,
            "title": "Novel vaccines and technology platforms"
        },
        {
            "endOffset": 43323,
            "parents": [],
            "secId": "s0040",
            "sentence": "A MDCK cell-based influenza H7N9 vaccine candidate, produced at Medigen, underwent clinical trials in Taiwan.",
            "startOffset": 43214,
            "title": "Novel vaccines and technology platforms"
        },
        {
            "endOffset": 45756,
            "parents": [],
            "secId": "s0045",
            "sentence": "As programmes expand in reach and complexity, innovation and creation of prevention opportunities become more relevant.",
            "startOffset": 45637,
            "title": "Conclusion: The life cycle and global opportunities"
        },
        {
            "endOffset": 21216,
            "parents": [],
            "secId": "s0010",
            "sentence": "The same will apply to OPV types 1 and 3, to be secured after future bOPV cessation.",
            "startOffset": 21132,
            "title": "Vaccine procurement and financing"
        },
        {
            "endOffset": 45504,
            "parents": [],
            "refoffsets": {
                "b0220": {
                    "endOffset": 45503,
                    "startOffset": 45499
                }
            },
            "secId": "s0045",
            "sentence": "Furthermore, innovative solutions are needed to address the challenge of declining vaccination coverage, affecting 25 countries from 2010 to 2015 [44].",
            "startOffset": 45353,
            "title": "Conclusion: The life cycle and global opportunities"
        },
        {
            "endOffset": 41260,
            "parents": [],
            "secId": "s0040",
            "sentence": "Flow-through chromatography core beads contain pores which soak up contaminating proteins and small DNA fragments, allowing virus or VLPs to pass through.",
            "startOffset": 41106,
            "title": "Novel vaccines and technology platforms"
        },
        {
            "endOffset": 35796,
            "parents": [],
            "refoffsets": {
                "b0115": {
                    "endOffset": 35795,
                    "startOffset": 35791
                }
            },
            "secId": "s0030",
            "sentence": "She also described the WHO\u2019s experience in facilitating access to new Ebola vaccine candidates during the outbreak [23].",
            "startOffset": 35676,
            "title": "WHO prequalification updates"
        },
        {
            "endOffset": 42166,
            "parents": [],
            "refoffsets": {
                "b0060": {
                    "endOffset": 42165,
                    "startOffset": 42161
                }
            },
            "secId": "s0040",
            "sentence": "Three doses showed 66.7% efficacy against severe rotavirus gastroenteritis among infants in Niger [12].",
            "startOffset": 42063,
            "title": "Novel vaccines and technology platforms"
        },
        {
            "endOffset": 20588,
            "parents": [],
            "secId": "s0010",
            "sentence": "UNICEF procures around 2.5 billion doses of 40 WHO-prequalified vaccines and distributes these to around 100 countries, managing demand and reallocating supply to level-out fluctuations and avert crises.",
            "startOffset": 20385,
            "title": "Vaccine procurement and financing"
        },
        {
            "endOffset": 37876,
            "parents": [],
            "secId": "s0035",
            "sentence": "PATH cost modelling studies confirm that such innovations can reduce the overall costs of vaccine delivery and waste disposal.",
            "startOffset": 37750,
            "title": "Innovative solutions for vaccine supply and distribution"
        },
        {
            "endOffset": 45005,
            "parents": [],
            "secId": "s0045",
            "sentence": "In the closing lecture, M. Friede, WHO, considered both novel vaccines and improvements made through advances in production, delivery and administration or protection level and duration.",
            "startOffset": 44819,
            "title": "Conclusion: The life cycle and global opportunities"
        },
        {
            "endOffset": 26744,
            "parents": [],
            "refoffsets": {
                "b0085": {
                    "endOffset": 26743,
                    "startOffset": 26739
                }
            },
            "secId": "s0015",
            "sentence": "One infected traveler resulted in quarantine of almost 17 000 people, 186 confirmed cases and 38 deaths [17].",
            "startOffset": 26635,
            "title": "Epidemic and pandemic vaccines"
        },
        {
            "endOffset": 43045,
            "parents": [],
            "refoffsets": {
                "b0180": {
                    "endOffset": 43044,
                    "startOffset": 43040
                }
            },
            "secId": "s0040",
            "sentence": "M. Lee, from Taiwan, shared the MDCK cell-derived influenza vaccine development using the high-risk pandemic H7N9 strain [36].",
            "startOffset": 42919,
            "title": "Novel vaccines and technology platforms"
        },
        {
            "endOffset": 28292,
            "parents": [],
            "secId": "s0015",
            "sentence": "M. Zuma, BioManguinhos, noted that high coverage with a full dose in routine immunization against yellow fever provides the best protection for children, while vaccine used at fractional doses can control outbreaks.",
            "startOffset": 28077,
            "title": "Epidemic and pandemic vaccines"
        },
        {
            "endOffset": 28005,
            "parents": [],
            "secId": "s0015",
            "sentence": "A. Precioso described Butantan\u2019s challenges to demonstrate efficacy of its two Zika vaccine candidates in the absence of disease transmission, established tests and agreed clinical endpoints.",
            "startOffset": 27814,
            "title": "Epidemic and pandemic vaccines"
        },
        {
            "endOffset": 37749,
            "parents": [],
            "secId": "s0035",
            "sentence": "An integrated reconstitution and administration device is being tested for delivery of heat-stable rotavirus vaccine.",
            "startOffset": 37632,
            "title": "Innovative solutions for vaccine supply and distribution"
        },
        {
            "endOffset": 20001,
            "parents": [],
            "refoffsets": {
                "b0035": {
                    "endOffset": 20000,
                    "startOffset": 19997
                }
            },
            "secId": "s0010",
            "sentence": "The WHO\u2019s Vaccine Price, Product, and Procurement platform addressed this gap by collecting vaccine pricing data from 144 countries (Fig. 2) [7].",
            "startOffset": 19856,
            "title": "Vaccine procurement and financing"
        },
        {
            "endOffset": 30115,
            "parents": [],
            "refoffsets": {
                "b0100": {
                    "endOffset": 30115,
                    "startOffset": 30111
                }
            },
            "secId": "s0020",
            "sentence": "An Africa-wide study on manufacturing cost-drivers and procurement in Africa was published. [20]",
            "startOffset": 30019,
            "title": "Innovative partnerships"
        },
        {
            "endOffset": 32467,
            "parents": [],
            "secId": "s0025",
            "sentence": "S. Bhaskaran shared an overview of BMGF\u2019s work in supporting the regulatory approval and lifecycle management of vaccines and drugs.",
            "startOffset": 32335,
            "title": "Regulatory convergence initiatives"
        },
        {
            "endOffset": 19037,
            "parents": [],
            "secId": "s0005",
            "sentence": "The vaccine supply base has grown from 5 manufacturers in 5 countries in 2001 to 15, in 11 countries, in 2016.",
            "startOffset": 18927,
            "title": "Introduction"
        },
        {
            "endOffset": 44043,
            "parents": [],
            "secId": "s0040",
            "sentence": "A VLP influenza vaccine is now licensed in India, and a recombinant rabies G-protein nanoparticle candidate is in phase III clinical trial.",
            "startOffset": 43904,
            "title": "Novel vaccines and technology platforms"
        },
        {
            "endOffset": 36639,
            "parents": [],
            "refoffsets": {
                "b0130": {
                    "endOffset": 36638,
                    "startOffset": 36634
                }
            },
            "secId": "s0030",
            "sentence": "Presently CTC is intended for campaign and strategic vaccination, not routine use [26].",
            "startOffset": 36552,
            "title": "WHO prequalification updates"
        },
        {
            "endOffset": 43446,
            "parents": [],
            "refoffsets": {
                "b0190": {
                    "endOffset": 43445,
                    "startOffset": 43441
                }
            },
            "secId": "s0040",
            "sentence": "Results indicate that inactivated, whole-virus H7N9 vaccine is more immunogenic than VLP, split and subunit antigens [38].",
            "startOffset": 43324,
            "title": "Novel vaccines and technology platforms"
        },
        {
            "endOffset": 23761,
            "parents": [],
            "refoffsets": {
                "b0060": {
                    "endOffset": 23760,
                    "startOffset": 23756
                }
            },
            "secId": "s0010",
            "sentence": "MSF has also been involved in clinical studies in collaboration with DCVMN manufacturers on vaccine thermo-stability and clinical trials of new products [12].",
            "startOffset": 23603,
            "title": "Vaccine procurement and financing"
        },
        {
            "endOffset": 45080,
            "parents": [],
            "secId": "s0045",
            "sentence": "A clear value proposition balancing likely risks and rewards is essential.",
            "startOffset": 45006,
            "title": "Conclusion: The life cycle and global opportunities"
        },
        {
            "endOffset": 38507,
            "parents": [],
            "refoffsets": {
                "b0135": {
                    "endOffset": 38506,
                    "startOffset": 38502
                }
            },
            "secId": "s0035",
            "sentence": "A CTC working group was established in 2016, at WHO [27].",
            "startOffset": 38450,
            "title": "Innovative solutions for vaccine supply and distribution"
        },
        {
            "endOffset": 24464,
            "parents": [],
            "refoffsets": {
                "b0065": {
                    "endOffset": 24463,
                    "startOffset": 24459
                }
            },
            "secId": "s0010",
            "sentence": "A Joint External Evaluation tool is available to support planning [13].",
            "startOffset": 24393,
            "title": "Vaccine procurement and financing"
        },
        {
            "endOffset": 32958,
            "parents": [],
            "refoffsets": {
                "b0110": {
                    "endOffset": 32957,
                    "startOffset": 32953
                }
            },
            "secId": "s0025",
            "sentence": "N. Dellepiane presented a comparative study of dossier format and contents, evaluation procedures and application forms for vaccine registration in different countries [22].",
            "startOffset": 32785,
            "title": "Regulatory convergence initiatives"
        },
        {
            "endOffset": 21664,
            "parents": [],
            "secId": "s0010",
            "sentence": "I. Lewis, UNICEF, reviewed the expected increase in the inactivated polio vaccine (IPV) availability in 2018.",
            "startOffset": 21555,
            "title": "Vaccine procurement and financing"
        },
        {
            "endOffset": 34035,
            "parents": [],
            "secId": "s0025",
            "sentence": "Y. Sohn noted that Korea, a PIC/S8 member country, accelerates approvals through exemption from GMP on-site inspection through agreements and mutual recognition.",
            "startOffset": 33809,
            "title": "Regulatory convergence initiatives"
        },
        {
            "endOffset": 38346,
            "parents": [],
            "secId": "s0035",
            "sentence": "Suitability for CTC must be tested, licensed and prequalified.",
            "startOffset": 38284,
            "title": "Innovative solutions for vaccine supply and distribution"
        },
        {
            "endOffset": 41975,
            "parents": [],
            "secId": "s0040",
            "sentence": "It is a live-attenuated, bovine-human rotavirus re-assortant grown in Vero cells, and includes G1, G2, G3, G4 and G9 serotypes.",
            "startOffset": 41848,
            "title": "Novel vaccines and technology platforms"
        },
        {
            "endOffset": 23900,
            "parents": [],
            "secId": "s0010",
            "sentence": "A procurement and financing discussion was moderated by S. Sobti, from CHAI.3",
            "startOffset": 23761,
            "title": "Vaccine procurement and financing"
        },
        {
            "endOffset": 24392,
            "parents": [],
            "secId": "s0010",
            "sentence": "S. Bryant, from WHO, elaborated on procurement of vaccines, such as yellow fever and Japanese encephalitis vaccines, for emergency outbreaks.",
            "startOffset": 24251,
            "title": "Vaccine procurement and financing"
        },
        {
            "endOffset": 30706,
            "parents": [],
            "secId": "s0020",
            "sentence": "A discussion on the challenges and benefits of public and private sector collaborations was moderated by G. Rockman of GHIF.6",
            "startOffset": 30537,
            "title": "Innovative partnerships"
        },
        {
            "endOffset": 18383,
            "parents": [],
            "secId": "s0005",
            "sentence": "DCVMN President, M. Datla, opened the meeting, noting the increase in global uptake of vaccines over the 18 years of DCVMN\u2019s existence.",
            "startOffset": 18248,
            "title": "Introduction"
        },
        {
            "endOffset": 19855,
            "parents": [],
            "refoffsets": {
                "b0030": {
                    "endOffset": 19854,
                    "startOffset": 19851
                }
            },
            "secId": "s0010",
            "sentence": "T. Cernuschi, WHO, noted that self-procuring, middle-income countries need better information on available products, suppliers, demand and supply forecasts and pricing information to improve decision-making and the management of vaccine shortages [6].",
            "startOffset": 19604,
            "title": "Vaccine procurement and financing"
        },
        {
            "endOffset": 23027,
            "parents": [],
            "secId": "s0010",
            "sentence": "The second is to support innovations to meet programmatic needs, improving coverage and equity.",
            "startOffset": 22932,
            "title": "Vaccine procurement and financing"
        },
        {
            "endOffset": 18248,
            "parents": [],
            "secId": "s0005",
            "sentence": "The meeting, hosted by SK Chemicals and co-hosted by the International Vaccine Institute (IVI) in Seoul, South Korea, focused on pandemics, epidemics and partnerships.",
            "startOffset": 18081,
            "title": "Introduction"
        },
        {
            "endOffset": 21131,
            "parents": [],
            "secId": "s0010",
            "sentence": "A unique challenge is presented by the OPV type 2 stockpile, established to support the Global Polio Eradication Initiative (GPEI) should type 2 outbreaks occur following the withdrawal of trivalent OPV.",
            "startOffset": 20928,
            "title": "Vaccine procurement and financing"
        },
        {
            "endOffset": 26878,
            "parents": [],
            "refoffsets": {
                "b0090": {
                    "endOffset": 26877,
                    "startOffset": 26873
                }
            },
            "secId": "s0015",
            "sentence": "MERS outbreaks have been mostly in Saudi Arabia, but global risk of MERS has increased through large-scale travel and migration [18].",
            "startOffset": 26745,
            "title": "Epidemic and pandemic vaccines"
        },
        {
            "endOffset": 18556,
            "parents": [],
            "secId": "s0005",
            "sentence": "J. Ahn welcomed attendees and expressed SK Chemical\u2019s commitment to healthcare and resolution of tackling pressing public-health issues through innovation and partnerships.",
            "startOffset": 18384,
            "title": "Introduction"
        },
        {
            "endOffset": 36477,
            "parents": [],
            "refoffsets": {
                "b0125": {
                    "endOffset": 36476,
                    "startOffset": 36472
                }
            },
            "secId": "s0030",
            "sentence": "A. Meek also reviewed the WHO position and guidance on bar codes and controlled temperature chain (CTC), referring to the PSPQ2 guideline on programmatic suitability [25].",
            "startOffset": 36306,
            "title": "WHO prequalification updates"
        },
        {
            "endOffset": 25421,
            "parents": [],
            "secId": "s0015",
            "sentence": "R. Hatchett outlined the gap between late preclinical development and proof-of-concept studies in humans for outbreak vaccines that led to the launch of the Coalition for Epidemic Preparedness Innovation (CEPI) in January 2017.",
            "startOffset": 25194,
            "title": "Epidemic and pandemic vaccines"
        },
        {
            "endOffset": 36196,
            "parents": [],
            "secId": "s0030",
            "sentence": "A. Meek discussed WHO\u2019s transition from Product Summary File (PSF) to CTD format, for vaccine prequalification submissions, as CTD use by regulatory agencies has increased.",
            "startOffset": 36024,
            "title": "WHO prequalification updates"
        },
        {
            "endOffset": 26500,
            "parents": [],
            "secId": "s0015",
            "sentence": "Successful use of fractional doses in Kinshasa, Democratic Republic of Congo, in 2016, helped alleviate insufficient supply.",
            "startOffset": 26376,
            "title": "Epidemic and pandemic vaccines"
        },
        {
            "endOffset": 36999,
            "parents": [],
            "secId": "s0035",
            "sentence": "D. Zehrung, PATH, reviewed novel primary containers and packaging technologies.",
            "startOffset": 36920,
            "title": "Innovative solutions for vaccine supply and distribution"
        },
        {
            "endOffset": 36863,
            "parents": [],
            "secId": "s0030",
            "sentence": "Additional clinical data is not needed, provided stability tests offer sufficient assurance that vaccines will meet the clinically-tested quality specifications.",
            "startOffset": 36702,
            "title": "WHO prequalification updates"
        },
        {
            "endOffset": 39675,
            "parents": [],
            "secId": "s0035",
            "sentence": "While currently voluntary, regulators and buyers may require packaging standards compliance in the future.",
            "startOffset": 39569,
            "title": "Innovative solutions for vaccine supply and distribution"
        },
        {
            "endOffset": 27370,
            "parents": [],
            "secId": "s0015",
            "sentence": "The European Vaccine Initiative (EVI), a product-development partnership represented by O. Leroy, helps control diseases of poverty by building a sustainable vaccine pipeline.",
            "startOffset": 27195,
            "title": "Epidemic and pandemic vaccines"
        },
        {
            "endOffset": 33634,
            "parents": [],
            "refoffsets": {
                "b0115": {
                    "endOffset": 33633,
                    "startOffset": 33629
                }
            },
            "secId": "s0025",
            "sentence": "B. Akanmori, WHO, shared his experience in building regulatory capacity through the African Vaccine Regulatory Forum (AVAREF), established by WHO in 2006 in 19 African countries, to overcome regulatory challenges, such as clinical trials, registration and post-licensure surveillance [23].",
            "startOffset": 33345,
            "title": "Regulatory convergence initiatives"
        },
        {
            "endOffset": 22130,
            "parents": [],
            "secId": "s0010",
            "sentence": "After 2020, China will have excess IPV capacity available for the international supply.",
            "startOffset": 22043,
            "title": "Vaccine procurement and financing"
        },
        {
            "endOffset": 42691,
            "parents": [],
            "refoffsets": {
                "b0175": {
                    "endOffset": 42593,
                    "startOffset": 42589
                }
            },
            "secId": "s0040",
            "sentence": "Clinical studies in 2014 demonstrated non-inferiority [35], the vaccine was approved in January 2015 and WHO prequalification was achieved in December 2015.",
            "startOffset": 42535,
            "title": "Novel vaccines and technology platforms"
        },
        {
            "endOffset": 29334,
            "parents": [],
            "secId": "s0020",
            "sentence": "Rabies elimination presents the next major opportunity to prevent 60 000 deaths annually, mostly among children in Africa and South East Asia,5 aiming zero human deaths from rabies by 2030.",
            "startOffset": 29046,
            "title": "Innovative partnerships"
        },
        {
            "endOffset": 40480,
            "parents": [],
            "refoffsets": {
                "b0155": {
                    "endOffset": 40479,
                    "startOffset": 40475
                }
            },
            "secId": "s0040",
            "sentence": "S. Kothari, presented an optimized production and purification of typhoid Vi polysaccharide from a clinical isolate from India [31].",
            "startOffset": 40348,
            "title": "Novel vaccines and technology platforms"
        },
        {
            "endOffset": 44767,
            "parents": [],
            "refoffsets": {
                "b0200": {
                    "endOffset": 44766,
                    "startOffset": 44762
                }
            },
            "secId": "s0040",
            "sentence": "OPA has been multiplexed, allowing accelerated vaccine development through reduced serum requirement, high analytical throughput and availability of robust, standardized procedures [40].",
            "startOffset": 44581,
            "title": "Novel vaccines and technology platforms"
        },
        {
            "endOffset": 40020,
            "parents": [],
            "secId": "s0035",
            "sentence": "Additional projects support waste and carbon footprint reduction for safe injection equipment.",
            "startOffset": 39926,
            "title": "Innovative solutions for vaccine supply and distribution"
        },
        {
            "endOffset": 43621,
            "parents": [],
            "secId": "s0040",
            "sentence": "A. Tomar, Cadila Biologicals, presented a new nanoparticle technology platform based on baculovirus and Sf9 cells expressing recombinant, properly folded, functional antigens.",
            "startOffset": 43446,
            "title": "Novel vaccines and technology platforms"
        },
        {
            "endOffset": 26634,
            "parents": [],
            "refoffsets": {
                "b0080": {
                    "endOffset": 26633,
                    "startOffset": 26629
                }
            },
            "secId": "s0015",
            "sentence": "J. Kim, IVI, described the MERS 2015 Korean outbreak, the first driven by human-to-human transmission outside of the Middle East [16].",
            "startOffset": 26500,
            "title": "Epidemic and pandemic vaccines"
        },
        {
            "endOffset": 21942,
            "parents": [],
            "secId": "s0010",
            "sentence": "L. Meng mentioned the China National Biotechnology Group\u2019s Sabin IPV vaccine, licensed in 2017, and its plans to produce 10 million doses by the end of 2017 to meet domestic market needs.",
            "startOffset": 21755,
            "title": "Vaccine procurement and financing"
        },
        {
            "endOffset": 29765,
            "parents": [],
            "secId": "s0020",
            "sentence": "Vaccines are produced at few African facilities, fulfilling only 1% of African vaccine needs.",
            "startOffset": 29672,
            "title": "Innovative partnerships"
        },
        {
            "endOffset": 30018,
            "parents": [],
            "secId": "s0020",
            "sentence": "AVMI formed in 2010 to advance vaccine manufacture in Africa through advocacy, resource mobilization and capacity-building.",
            "startOffset": 29895,
            "title": "Innovative partnerships"
        },
        {
            "endOffset": 31081,
            "parents": [],
            "secId": "s0020",
            "sentence": "A. Gil described Sinergium\u2019s partnerships with multinational companies based on a public-private consortium model.",
            "startOffset": 30967,
            "title": "Innovative partnerships"
        },
        {
            "endOffset": 40699,
            "parents": [],
            "secId": "s0040",
            "sentence": "Downstream improvements optimized diafiltration and replaced precipitation steps with chromatography, resulting in 30\u201340% higher Vi recovery.",
            "startOffset": 40558,
            "title": "Novel vaccines and technology platforms"
        },
        {
            "endOffset": 25552,
            "parents": [],
            "refoffsets": {
                "b0070": {
                    "endOffset": 25551,
                    "startOffset": 25547
                }
            },
            "secId": "s0015",
            "sentence": "CEPI aims to speed outbreak preparedness and response, ensure market predictability and promote equity of access to vaccines [14].",
            "startOffset": 25422,
            "title": "Epidemic and pandemic vaccines"
        },
        {
            "endOffset": 44233,
            "parents": [],
            "secId": "s0040",
            "sentence": "M. Nahm discussed immunoassay technologies to test vaccines against Streptococcus pneumoniae, a common nasopharyngeal, gram-positive bacterium causing pneumonia, otitis media and meningitis.",
            "startOffset": 44043,
            "title": "Novel vaccines and technology platforms"
        },
        {
            "endOffset": 45903,
            "parents": [],
            "secId": "s0045",
            "sentence": "A major benefit of the DCVMN annual meeting is facilitation of communication between emerging countries\u2019 industry and global health organizations.",
            "startOffset": 45757,
            "title": "Conclusion: The life cycle and global opportunities"
        },
        {
            "endOffset": 23210,
            "parents": [],
            "refoffsets": {
                "b0045": {
                    "endOffset": 23209,
                    "startOffset": 23206
                }
            },
            "secId": "s0010",
            "sentence": "The third is to actively build industry engagement, by publishing supply and procurement roadmaps for each product and sharing both budget-limited and strategic demand-forecasts [9].",
            "startOffset": 23028,
            "title": "Vaccine procurement and financing"
        },
        {
            "endOffset": 20070,
            "parents": [],
            "secId": "s0010",
            "sentence": "The initiative aims to inform global supply policies and strategies.",
            "startOffset": 20002,
            "title": "Vaccine procurement and financing"
        },
        {
            "endOffset": 27195,
            "parents": [],
            "refoffsets": {
                "b0090": {
                    "endOffset": 27194,
                    "startOffset": 27190
                }
            },
            "secId": "s0015",
            "sentence": "A DNA candidate vaccine has completed preclinical studies and is approved for first-in-human trials [18].",
            "startOffset": 27090,
            "title": "Epidemic and pandemic vaccines"
        },
        {
            "endOffset": 34871,
            "parents": [],
            "secId": "s0025",
            "sentence": "E. Cooke concluded that communication among regulators is a key to creating solutions to outbreak control.",
            "startOffset": 34765,
            "title": "Regulatory convergence initiatives"
        },
        {
            "endOffset": 25163,
            "parents": [],
            "secId": "s0010",
            "sentence": "These provisions resulted in 95% of vaccine costs being supported by national budgets in most Latin American countries.",
            "startOffset": 25044,
            "title": "Vaccine procurement and financing"
        },
        {
            "endOffset": 36305,
            "parents": [],
            "secId": "s0030",
            "sentence": "Challenges are anticipated for products licensed in countries not using CTD, and differences in CTD formats.",
            "startOffset": 36197,
            "title": "WHO prequalification updates"
        },
        {
            "endOffset": 37328,
            "parents": [],
            "secId": "s0035",
            "sentence": "Apiject and Rommelag are developing a blow-fill-seal design for parenteral delivery in a multiple single-dose package configuration.",
            "startOffset": 37196,
            "title": "Innovative solutions for vaccine supply and distribution"
        },
        {
            "endOffset": 43756,
            "parents": [],
            "secId": "s0040",
            "sentence": "The platform has flexibility to manufacture clinical-grade material in 3\u20134 months, thus is suitable for pandemic or outbreak vaccines.",
            "startOffset": 43622,
            "title": "Novel vaccines and technology platforms"
        },
        {
            "endOffset": 34709,
            "parents": [],
            "secId": "s0025",
            "sentence": "D. Dat from Vabiotech added that surrogate efficacy endpoints could be considered for approval of new vaccines, and that, despite harmonized dossiers within ASEAN9 countries, redundant inspections or supplemental clinical studies still delay registrations.",
            "startOffset": 34399,
            "title": "Regulatory convergence initiatives"
        },
        {
            "endOffset": 26948,
            "parents": [],
            "secId": "s0015",
            "sentence": "There have been 2081 cases with a case fatality rate of 35% (Fig. 4).",
            "startOffset": 26879,
            "title": "Epidemic and pandemic vaccines"
        },
        {
            "endOffset": 40216,
            "parents": [],
            "secId": "s0035",
            "sentence": "The next tender round will require industry reporting on \u201cgreen-manufacturing\u201d, implementation of weight, volume and local production criteria, and introduction of electronic tendering processes.",
            "startOffset": 40021,
            "title": "Innovative solutions for vaccine supply and distribution"
        },
        {
            "endOffset": 40308,
            "parents": [],
            "secId": "s0035",
            "sentence": "A vaccine arrival report application has been tested and will be launched globally in 2018.",
            "startOffset": 40217,
            "title": "Innovative solutions for vaccine supply and distribution"
        },
        {
            "endOffset": 39282,
            "parents": [],
            "secId": "s0035",
            "sentence": "Temptime is also developing a 2D barcode for VVMs with a corresponding reader for both, ideally for use with cellphone application, to improve patient safety and address international anti-counterfeiting, track-and-trace and serialization requirements.",
            "startOffset": 39030,
            "title": "Innovative solutions for vaccine supply and distribution"
        },
        {
            "endOffset": 39925,
            "parents": [],
            "secId": "s0035",
            "sentence": "Countries\u2019 and manufacturers\u2019 awareness of CTC has been promoted, and CTC is now a tender-evaluation criterion from 2017.",
            "startOffset": 39804,
            "title": "Innovative solutions for vaccine supply and distribution"
        },
        {
            "endOffset": 41326,
            "parents": [],
            "secId": "s0040",
            "sentence": "Wide applicability of core beads for many vaccines was discussed.",
            "startOffset": 41261,
            "title": "Novel vaccines and technology platforms"
        },
        {
            "endOffset": 39568,
            "parents": [],
            "refoffsets": {
                "b0145": {
                    "endOffset": 39567,
                    "startOffset": 39563
                }
            },
            "secId": "s0035",
            "sentence": "WHO\u2019s 2015 generic preferred product profile for vaccines recommends barcodes with GS112 standards on all packaging levels used by manufacturers, except primary packaging [29].",
            "startOffset": 39374,
            "title": "Innovative solutions for vaccine supply and distribution"
        },
        {
            "endOffset": 24250,
            "parents": [],
            "secId": "s0010",
            "sentence": "L. Meng described the Chinese centralized procurement system, with an annual USD 300 million budget, enabling public and private manufacturers to participate in tenders.",
            "startOffset": 24081,
            "title": "Vaccine procurement and financing"
        },
        {
            "endOffset": 19570,
            "parents": [],
            "secId": "s0005",
            "sentence": "A recent project supported the introduction of Eubiologics\u2019 new oral cholera vaccine to Gavi countries.",
            "startOffset": 19467,
            "title": "Introduction"
        },
        {
            "endOffset": 29671,
            "parents": [],
            "secId": "s0020",
            "sentence": "Africa has 16% of the global population, high population growth and the highest childhood mortality rate, but represents only 5.5% of the global vaccine market.",
            "startOffset": 29511,
            "title": "Innovative partnerships"
        },
        {
            "endOffset": 37468,
            "parents": [],
            "secId": "s0035",
            "sentence": "Maropack and a multinational are evaluating the blow-fill-seal technology, to date used only for non-heat sensitive products, for vaccines.",
            "startOffset": 37329,
            "title": "Innovative solutions for vaccine supply and distribution"
        },
        {
            "endOffset": 38155,
            "parents": [],
            "refoffsets": {
                "b0010": {
                    "endOffset": 38071,
                    "startOffset": 38068
                }
            },
            "secId": "s0035",
            "sentence": "A. Kahn provided an update on the WHO CTC, a specific set of conditions allowing vaccine storage and transportation outside of the traditional 2 to 8 \u00b0C cold chain for a specified time period [2], applied to vaccines tolerating temperatures of at least 40 \u00b0C for at least 3 days.",
            "startOffset": 37876,
            "title": "Innovative solutions for vaccine supply and distribution"
        },
        {
            "endOffset": 34999,
            "parents": [],
            "secId": "s0025",
            "sentence": "WHO will continue to consider published evidence and proposals to improve the registration of vaccines in developing countries.",
            "startOffset": 34872,
            "title": "Regulatory convergence initiatives"
        },
        {
            "endOffset": 39373,
            "parents": [],
            "secId": "s0035",
            "sentence": "U. Kreysa presented GS1\u2032s role in providing global, cross-industry standards for barcoding.",
            "startOffset": 39282,
            "title": "Innovative solutions for vaccine supply and distribution"
        },
        {
            "endOffset": 41105,
            "parents": [],
            "secId": "s0040",
            "sentence": "L. Liu, from Institute of Medical Biology, Chinese Academy of Medical Sciences, and M. Lundgren, GE Healthcare, presented enterovirus 71 vaccine developed in human diploid cells, or as virus like particles (VLPs) from insect cells, produced in a wave bioreactor, then passed through flow-through chromatography and two binding steps.",
            "startOffset": 40772,
            "title": "Novel vaccines and technology platforms"
        },
        {
            "endOffset": 42782,
            "parents": [],
            "secId": "s0040",
            "sentence": "The fill-seal presentation was validated, approved and prequalified by WHO in August 2017.",
            "startOffset": 42692,
            "title": "Novel vaccines and technology platforms"
        },
        {
            "endOffset": 22703,
            "parents": [],
            "secId": "s0010",
            "sentence": "The first is to support governments in evaluating vaccine introduction and forecasting.",
            "startOffset": 22616,
            "title": "Vaccine procurement and financing"
        },
        {
            "endOffset": 32048,
            "parents": [],
            "refoffsets": {
                "b0105": {
                    "endOffset": 32026,
                    "startOffset": 32022
                }
            },
            "secId": "s0025",
            "sentence": "E. Cooke reviewed the WHO's role in vaccine registration in developing countries, including generating guidance documents such as the Emergency Use and Assessment Listing (EUAL) [21] of pipeline vaccines.",
            "startOffset": 31844,
            "title": "Regulatory convergence initiatives"
        },
        {
            "endOffset": 42534,
            "parents": [],
            "secId": "s0040",
            "sentence": "Following reformulation of the OCV developed for Vietnam by IVI, the technology and process was optimized at Eubiologics.",
            "startOffset": 42413,
            "title": "Novel vaccines and technology platforms"
        },
        {
            "endOffset": 39803,
            "parents": [],
            "secId": "s0035",
            "sentence": "I. Lewis gave an update on UNICEF\u2019s barcoding project.",
            "startOffset": 39749,
            "title": "Innovative solutions for vaccine supply and distribution"
        },
        {
            "endOffset": 29894,
            "parents": [],
            "secId": "s0020",
            "sentence": "Public health emergencies, such as Ebola, highlighted the regional vulnerability and galvanized support for local manufacturing.",
            "startOffset": 29766,
            "title": "Innovative partnerships"
        },
        {
            "endOffset": 20265,
            "parents": [],
            "secId": "s0010",
            "sentence": "It is also involved in global dialogue facilitated by The Humanitarian Mechanism, launched this year to facilitate timely access to and affordability of vaccines during humanitarian emergencies.",
            "startOffset": 20071,
            "title": "Vaccine procurement and financing"
        },
        {
            "endOffset": 31337,
            "parents": [],
            "secId": "s0020",
            "sentence": "It was successful with influenza, then pneumococcal and, lately, HPV vaccines\u2019 supply, in Argentina.",
            "startOffset": 31237,
            "title": "Innovative partnerships"
        },
        {
            "endOffset": 20715,
            "parents": [],
            "secId": "s0010",
            "sentence": "Since 2010, UNICEF has responded to around 300 humanitarian situations in 90 countries annually, with a peak in 2016 (Fig. 3).",
            "startOffset": 20589,
            "title": "Vaccine procurement and financing"
        },
        {
            "endOffset": 23435,
            "parents": [],
            "secId": "s0010",
            "sentence": "She acknowledged the critical role of DCVMN manufacturers in improving affordability and access.",
            "startOffset": 23339,
            "title": "Vaccine procurement and financing"
        },
        {
            "endOffset": 34189,
            "parents": [],
            "refoffsets": {
                "b0120": {
                    "endOffset": 34188,
                    "startOffset": 34184
                }
            },
            "secId": "s0025",
            "sentence": "B. Akanmori mentioned that joint reviews are a successful mechanism to accelerate review of clinical trials and registration applications in Africa [24].",
            "startOffset": 34036,
            "title": "Regulatory convergence initiatives"
        },
        {
            "endOffset": 33808,
            "parents": [],
            "secId": "s0025",
            "sentence": "The experts also discussed the challenges of improving epidemic regulatory preparedness, particularly in countries where Ebola, Zika, MERS, and other outbreaks could surface.",
            "startOffset": 33634,
            "title": "Regulatory convergence initiatives"
        },
        {
            "endOffset": 31588,
            "parents": [],
            "secId": "s0020",
            "sentence": "P. Khoury from Ology Bioservices discussed a fill-finish service to satisfy bulk manufacturers, small manufacturers and surge capacity needs.",
            "startOffset": 31447,
            "title": "Innovative partnerships"
        },
        {
            "endOffset": 31658,
            "parents": [],
            "secId": "s0020",
            "sentence": "B. Abela supported partnerships to sustain access to rabies vaccines.",
            "startOffset": 31589,
            "title": "Innovative partnerships"
        },
        {
            "endOffset": 25787,
            "parents": [],
            "secId": "s0015",
            "sentence": "Targeted times are 16 weeks from antigen identification to clinical trial batch availability, 6 weeks from clinical trial start to demonstration of likely clinical benefit, and 8 weeks from go-ahead to production of 100 million doses.",
            "startOffset": 25553,
            "title": "Epidemic and pandemic vaccines"
        },
        {
            "endOffset": 38449,
            "parents": [],
            "secId": "s0035",
            "sentence": "Key tools are Vaccine Vial Monitors (VVMs) at point-of-use and a peak threshold temperature indicator.",
            "startOffset": 38347,
            "title": "Innovative solutions for vaccine supply and distribution"
        },
        {
            "endOffset": 31446,
            "parents": [],
            "secId": "s0020",
            "sentence": "K. Ella from Bharat Biotech described their PATH partnership on rotavirus, typhoid and Chikungunya vaccines.",
            "startOffset": 31338,
            "title": "Innovative partnerships"
        },
        {
            "endOffset": 44453,
            "parents": [],
            "secId": "s0040",
            "sentence": "Polysaccharide conjugated vaccines were licensed in 2000 and 2010 based on immunogenicity data, without efficacy studies, thus reducing costs of new product development.",
            "startOffset": 44284,
            "title": "Novel vaccines and technology platforms"
        },
        {
            "endOffset": 18735,
            "parents": [],
            "refoffsets": {
                "b0005": {
                    "endOffset": 18734,
                    "startOffset": 18731
                }
            },
            "secId": "s0005",
            "sentence": "Korean Deputy Minister of Health and Welfare, D. Kwon, emphasized that vaccines are part of the social security of Korea and described efforts to expand support for vaccines [1].",
            "startOffset": 18557,
            "title": "Introduction"
        },
        {
            "endOffset": 21416,
            "parents": [],
            "secId": "s0010",
            "sentence": "R. Rustan provided an overview of BioFarma\u2019s supply of bOPV and polio vaccine bulk over the last five years and estimates for supply from 2018 to 2021, for both routine and supplementary immunization.",
            "startOffset": 21216,
            "title": "Vaccine procurement and financing"
        },
        {
            "endOffset": 27544,
            "parents": [],
            "secId": "s0015",
            "sentence": "EVI\u2019s EC-funded Zikavax project, in partnership with Institute Pasteur, Themis and CEA, fast-tracks development of vaccine candidates using a live-attenuated measles vector.",
            "startOffset": 27371,
            "title": "Epidemic and pandemic vaccines"
        },
        {
            "endOffset": 30966,
            "parents": [],
            "secId": "s0020",
            "sentence": "M. Makhoana from Biovac announced a product-development partnership with PATH7 on Group B Streptococcus (GBS) vaccine in response to African needs, using a conjugate technology developed with BioNet.",
            "startOffset": 30707,
            "title": "Innovative partnerships"
        },
        {
            "endOffset": 26182,
            "parents": [],
            "secId": "s0015",
            "sentence": "Forty countries are targeted and 1.4 billion doses of vaccine needed.",
            "startOffset": 26113,
            "title": "Epidemic and pandemic vaccines"
        },
        {
            "endOffset": 30537,
            "parents": [],
            "secId": "s0020",
            "sentence": "Integration and alignment of purpose and conscientious building of relationships and trust among partners is imperative for sustainable supply.",
            "startOffset": 30394,
            "title": "Innovative partnerships"
        },
        {
            "endOffset": 28931,
            "parents": [],
            "refoffsets": {
                "b0095": {
                    "endOffset": 28930,
                    "startOffset": 28926
                }
            },
            "secId": "s0020",
            "sentence": "B. Abela-Ridder presented WHO\u2019s initiatives to control neglected tropical diseases [19].",
            "startOffset": 28843,
            "title": "Innovative partnerships"
        },
        {
            "endOffset": 29510,
            "parents": [],
            "secId": "s0020",
            "sentence": "W. Ampofo spoke about the novel African Vaccine Manufacturing Initiative (AVMI).",
            "startOffset": 29430,
            "title": "Innovative partnerships"
        },
        {
            "endOffset": 35676,
            "parents": [],
            "secId": "s0030",
            "sentence": "Communication, technical assistance and regulatory strategies are in place to reduce these.",
            "startOffset": 35585,
            "title": "WHO prequalification updates"
        },
        {
            "endOffset": 32544,
            "parents": [],
            "secId": "s0025",
            "sentence": "Key strategic principles are: Reliance, Re-engineering, and Regionalization.",
            "startOffset": 32468,
            "title": "Regulatory convergence initiatives"
        },
        {
            "endOffset": 36551,
            "parents": [],
            "secId": "s0030",
            "sentence": "Label space constraints and cost implications of barcodes are recognized.",
            "startOffset": 36478,
            "title": "WHO prequalification updates"
        },
        {
            "endOffset": 36701,
            "parents": [],
            "secId": "s0030",
            "sentence": "Stability must be proven, regardless of remaining shelf-life.",
            "startOffset": 36640,
            "title": "WHO prequalification updates"
        },
        {
            "endOffset": 21755,
            "parents": [],
            "secId": "s0010",
            "sentence": "Offers have been received from more than 10 manufacturers for the IPV tender of 2019\u20132022.",
            "startOffset": 21665,
            "title": "Vaccine procurement and financing"
        },
        {
            "endOffset": 26004,
            "parents": [],
            "refoffsets": {
                "b0075": {
                    "endOffset": 26003,
                    "startOffset": 25999
                }
            },
            "secId": "s0015",
            "sentence": "S. Briand, presented the WHO-strategy for eliminating yellow fever epidemics (EYE) by 2026 [15].",
            "startOffset": 25908,
            "title": "Epidemic and pandemic vaccines"
        },
        {
            "endOffset": 34398,
            "parents": [],
            "secId": "s0025",
            "sentence": "Solutions may include human challenge trials and investigational product stockpiles.",
            "startOffset": 34314,
            "title": "Regulatory convergence initiatives"
        },
        {
            "endOffset": 24800,
            "parents": [],
            "secId": "s0010",
            "sentence": "There is a need for public organizations to accept higher prices to ensure sustainability.",
            "startOffset": 24710,
            "title": "Vaccine procurement and financing"
        },
        {
            "endOffset": 26112,
            "parents": [],
            "secId": "s0015",
            "sentence": "Yellow fever is re-emerging despite availability of an effective vaccine, and now presents a global threat.",
            "startOffset": 26005,
            "title": "Epidemic and pandemic vaccines"
        },
        {
            "endOffset": 45352,
            "parents": [],
            "refoffsets": {
                "b0205": {
                    "endOffset": 45302,
                    "startOffset": 45295
                },
                "b0210": {
                    "endOffset": 45302,
                    "startOffset": 45295
                },
                "b0215": {
                    "endOffset": 45302,
                    "startOffset": 45295
                }
            },
            "secId": "s0045",
            "sentence": "Vaccination of older adults can prevent illnesses resulting from the age-related decline of immune system function [41\u201343] as well as consequences of antibiotic resistance.",
            "startOffset": 45180,
            "title": "Conclusion: The life cycle and global opportunities"
        },
        {
            "endOffset": 26375,
            "parents": [],
            "secId": "s0015",
            "sentence": "Population immunity must be increased in high-risk, endemic countries.",
            "startOffset": 26305,
            "title": "Epidemic and pandemic vaccines"
        },
        {
            "endOffset": 28076,
            "parents": [],
            "secId": "s0015",
            "sentence": "Human challenge studies may be needed to advance clinical development.",
            "startOffset": 28006,
            "title": "Epidemic and pandemic vaccines"
        },
        {
            "endOffset": 38781,
            "parents": [],
            "secId": "s0035",
            "sentence": "A new VVM11 will be commercialized in 2018, and WHO is considering a VVM180.",
            "startOffset": 38705,
            "title": "Innovative solutions for vaccine supply and distribution"
        },
        {
            "endOffset": 26304,
            "parents": [],
            "secId": "s0015",
            "sentence": "In 2016 and 2017 there were major urban outbreaks in Africa and South America, and the disease spread to other countries.",
            "startOffset": 26183,
            "title": "Epidemic and pandemic vaccines"
        },
        {
            "endOffset": 42412,
            "parents": [],
            "secId": "s0040",
            "sentence": "The fill-seal technology for inactivated Oral Cholera Vaccine (OCV), described by Y. Baik, Eubiologics, facilitates easy and safe administration of vaccines.",
            "startOffset": 42255,
            "title": "Novel vaccines and technology platforms"
        },
        {
            "endOffset": 39029,
            "parents": [],
            "secId": "s0035",
            "sentence": "A novel VVM+ is in development for CTC use, combining in a single indicator the cumulative VVM response for temperatures up to 37 \u00b0C, and the rapid-response, peak-threshold indicator for high-temperature exposure at 40 \u00b0C, 44 \u00b0C or 50 \u00b0C (Fig. 5).",
            "startOffset": 38782,
            "title": "Innovative solutions for vaccine supply and distribution"
        },
        {
            "endOffset": 38283,
            "parents": [],
            "refoffsets": {
                "b0130": {
                    "endOffset": 38282,
                    "startOffset": 38278
                }
            },
            "secId": "s0035",
            "sentence": "ECTC,10 refers to vaccines tolerating temperatures above 8 \u00b0C for a specified time [26].",
            "startOffset": 38156,
            "title": "Innovative solutions for vaccine supply and distribution"
        },
        {
            "endOffset": 30393,
            "parents": [],
            "secId": "s0020",
            "sentence": "The current pipeline has many similar vaccines, and prioritizing candidates is challenging.",
            "startOffset": 30302,
            "title": "Innovative partnerships"
        },
        {
            "endOffset": 41847,
            "parents": [],
            "refoffsets": {
                "b0170": {
                    "endOffset": 41846,
                    "startOffset": 41842
                }
            },
            "secId": "s0040",
            "sentence": "S. Jadhav, Serum Institute of India, reported on the first thermostable, lyophilized, oral rotavirus vaccine, now available in India [34].",
            "startOffset": 41709,
            "title": "Novel vaccines and technology platforms"
        },
        {
            "endOffset": 35584,
            "parents": [],
            "secId": "s0030",
            "sentence": "Common challenges during prequalification include incomplete dossiers, lack of data (at commercial scale, on cell bank characterization, or lot consistency), inappropriate clinical trial comparator product, non-registration of clinical trials, deficient quality systems, differences between national regulations and deviations from programmatic suitability criteria.",
            "startOffset": 35218,
            "title": "WHO prequalification updates"
        },
        {
            "endOffset": 38619,
            "parents": [],
            "secId": "s0035",
            "sentence": "M. Rush, Temptime,11 outlined innovations in temperature monitoring.",
            "startOffset": 38507,
            "title": "Innovative solutions for vaccine supply and distribution"
        },
        {
            "endOffset": 28473,
            "parents": [],
            "secId": "s0015",
            "sentence": "S. Desai, Zydus-Cadila, discussed the need to build a comprehensive response to Congo-Crimea hemorrhagic fever, including veterinary and human vaccines and post-exposure treatment.",
            "startOffset": 28293,
            "title": "Epidemic and pandemic vaccines"
        },
        {
            "endOffset": 43213,
            "parents": [],
            "refoffsets": {
                "b0185": {
                    "endOffset": 43212,
                    "startOffset": 43208
                }
            },
            "secId": "s0040",
            "sentence": "Enhanced surveillance for Asian H7N9 viruses in humans and poultry was recommended, as 1557 human cases and 605 deaths were reported to WHO between 2013 and 2017 [37].",
            "startOffset": 43046,
            "title": "Novel vaccines and technology platforms"
        },
        {
            "endOffset": 31236,
            "parents": [],
            "secId": "s0020",
            "sentence": "Sinergium provided the facility, the multinational provided the product and related technology and local government committed to long-term market tenders.",
            "startOffset": 31082,
            "title": "Innovative partnerships"
        },
        {
            "endOffset": 34764,
            "parents": [],
            "secId": "s0025",
            "sentence": "H. Iyer noted that outbreak response time is critical.",
            "startOffset": 34710,
            "title": "Regulatory convergence initiatives"
        },
        {
            "endOffset": 41709,
            "parents": [],
            "secId": "s0040",
            "sentence": "A pentavalent GBS conjugate vaccine for pregnant women will be based on purified capsular polysaccharide and conjugates for GBS serotypes Ia, Ib, II, III & V.",
            "startOffset": 41551,
            "title": "Novel vaccines and technology platforms"
        },
        {
            "endOffset": 39749,
            "parents": [],
            "refoffsets": {
                "b0150": {
                    "endOffset": 39748,
                    "startOffset": 39744
                }
            },
            "secId": "s0035",
            "sentence": "Pilot projects implementation in developing countries was described [30].",
            "startOffset": 39676,
            "title": "Innovative solutions for vaccine supply and distribution"
        },
        {
            "endOffset": 27089,
            "parents": [],
            "secId": "s0015",
            "sentence": "There are many vaccine candidates, mostly in preclinical testing, but lack of correlates of protection and animal models present challenges.",
            "startOffset": 26949,
            "title": "Epidemic and pandemic vaccines"
        },
        {
            "endOffset": 31809,
            "parents": [],
            "secId": "s0020",
            "sentence": "G. Rockman concluded that innovation through complex partnerships requires sharing of experience and information, and transparency in decision-making.",
            "startOffset": 31659,
            "title": "Innovative partnerships"
        },
        {
            "endOffset": 22530,
            "parents": [],
            "secId": "s0010",
            "sentence": "Priorities in the management of polio for the next six months are surveillance, halting transmission and containment.",
            "startOffset": 22413,
            "title": "Vaccine procurement and financing"
        },
        {
            "endOffset": 18926,
            "parents": [],
            "refoffsets": {
                "b0010": {
                    "endOffset": 18925,
                    "startOffset": 18922
                }
            },
            "secId": "s0005",
            "sentence": "S. Berkley reported that immunization coverage of DTP2-containing vaccines has increased by 20%-points since the launch of Gavi support for poorest countries [2].",
            "startOffset": 18735,
            "title": "Introduction"
        },
        {
            "endOffset": 19266,
            "parents": [],
            "refoffsets": {
                "b0015": {
                    "endOffset": 19193,
                    "startOffset": 19188
                },
                "b0020": {
                    "endOffset": 19193,
                    "startOffset": 19188
                },
                "b0025": {
                    "endOffset": 19265,
                    "startOffset": 19262
                }
            },
            "secId": "s0005",
            "sentence": "While the impact of increased vaccination coverage has been substantial [3,4], still 19.5 million newborns annually do not receive basic vaccines [5].",
            "startOffset": 19116,
            "title": "Introduction"
        },
        {
            "endOffset": 32785,
            "parents": [],
            "secId": "s0025",
            "sentence": "His vision for an efficient, transparent and predictable regulatory pathway for global health products includes moving quickly from manufacturing country, through prequalification, into receiving countries, through adoption of new products.",
            "startOffset": 32545,
            "title": "Regulatory convergence initiatives"
        },
        {
            "endOffset": 20384,
            "parents": [],
            "refoffsets": {
                "b0040": {
                    "endOffset": 20383,
                    "startOffset": 20380
                }
            },
            "secId": "s0010",
            "sentence": "S. Rautio outlined UNICEF\u2019s stockpiling strategies, priorities and forecasting, funding and contracting activities [8].",
            "startOffset": 20265,
            "title": "Vaccine procurement and financing"
        },
        {
            "endOffset": 25043,
            "parents": [],
            "secId": "s0010",
            "sentence": "O. Vargas outlined four key principles of the PAHO Revolving Fund for pooled procurement which made immunization in Latin America successful and sustainable: local vaccine legislation, shared goals, solidarity and financial co-responsibility.",
            "startOffset": 24801,
            "title": "Vaccine procurement and financing"
        },
        {
            "endOffset": 42062,
            "parents": [],
            "secId": "s0040",
            "sentence": "The lyophilized vaccine is stable at temperatures not higher than 25 \u00b0C for 30 months.",
            "startOffset": 41976,
            "title": "Novel vaccines and technology platforms"
        },
        {
            "endOffset": 37093,
            "parents": [],
            "secId": "s0035",
            "sentence": "Pre-formed plastic vials are being successfully used for oral rotavirus and cholera vaccines.",
            "startOffset": 37000,
            "title": "Innovative solutions for vaccine supply and distribution"
        },
        {
            "endOffset": 37195,
            "parents": [],
            "secId": "s0035",
            "sentence": "The compact pre-filled auto-disposable Uniject container is used by BioFarma for hepatitis B vaccine.",
            "startOffset": 37094,
            "title": "Innovative solutions for vaccine supply and distribution"
        },
        {
            "endOffset": 45636,
            "parents": [],
            "secId": "s0045",
            "sentence": "Dr. Friede concluded by appreciating the impact of vaccines on health at all ages, and continual innovation by the vaccine industry.",
            "startOffset": 45504,
            "title": "Conclusion: The life cycle and global opportunities"
        },
        {
            "endOffset": 18080,
            "parents": [],
            "secId": "s0005",
            "sentence": "The 18th Annual General Meeting of the Developing Countries Vaccine Manufacturers\u2019 Network (DCVMN) gathered over 270 vaccine experts from 38 member-companies in emerging countries, 23 non-member companies and 28 non-industry organizations to inspire innovation and promote global access to vaccines.",
            "startOffset": 17781,
            "title": "Introduction"
        },
        {
            "endOffset": 29430,
            "parents": [],
            "secId": "s0020",
            "sentence": "Manufacturers are encouraged to prequalify novel rabies products in supporting this initiative.",
            "startOffset": 29335,
            "title": "Innovative partnerships"
        },
        {
            "endOffset": 28819,
            "parents": [],
            "secId": "s0015",
            "sentence": "M. Ibna Masud outlined the technology transfer between Incepta, Bangladesh, and IVI on cholera vaccine, with clinical studies in progress.",
            "startOffset": 28681,
            "title": "Epidemic and pandemic vaccines"
        },
        {
            "endOffset": 40772,
            "parents": [],
            "secId": "s0040",
            "sentence": "Future efforts will focus on reducing product impurities and endotoxins.",
            "startOffset": 40700,
            "title": "Novel vaccines and technology platforms"
        },
        {
            "endOffset": 22931,
            "parents": [],
            "secId": "s0010",
            "sentence": "The Total Systems Effectiveness sustainability initiative started in 2017 to assist countries to assess future demand, understand trade-offs and make decisions for delivery of best overall value and coverage in varied settings.",
            "startOffset": 22704,
            "title": "Vaccine procurement and financing"
        },
        {
            "endOffset": 44283,
            "parents": [],
            "secId": "s0040",
            "sentence": "Polysaccharide vaccines became available in 1987.",
            "startOffset": 44234,
            "title": "Novel vaccines and technology platforms"
        },
        {
            "endOffset": 27585,
            "parents": [],
            "secId": "s0015",
            "sentence": "The first candidate is in Phase I trial.",
            "startOffset": 27545,
            "title": "Epidemic and pandemic vaccines"
        },
        {
            "endOffset": 43903,
            "parents": [],
            "secId": "s0040",
            "sentence": "It has been used to produce VLPs for seasonal and pandemic influenza, as well as protein micelles of rabies, Ebola, MERS, Zika and other antigens.",
            "startOffset": 43757,
            "title": "Novel vaccines and technology platforms"
        },
        {
            "endOffset": 29045,
            "parents": [],
            "secId": "s0020",
            "sentence": "Multiple partners pledged support for the control, elimination or eradication of 10 prioritized diseases by 2020.",
            "startOffset": 28932,
            "title": "Innovative partnerships"
        },
        {
            "endOffset": 22615,
            "parents": [],
            "secId": "s0010",
            "sentence": "M. Malhame described Gavi\u2019s progress in three strategic priorities from 2016 to 2020.",
            "startOffset": 22530,
            "title": "Vaccine procurement and financing"
        },
        {
            "endOffset": 24080,
            "parents": [],
            "secId": "s0010",
            "sentence": "S. Rautio commented that UNICEF continues to support countries graduating from Gavi through the Vaccine Procurement Practitioners Exchange Forum, and through Procurement Services.",
            "startOffset": 23901,
            "title": "Vaccine procurement and financing"
        },
        {
            "endOffset": 25908,
            "parents": [],
            "secId": "s0015",
            "sentence": "Initial proposals for Middle East Respiratory Syndrome (MERS), Lassa and Nipah virus vaccines are undergoing evaluation.",
            "startOffset": 25788,
            "title": "Epidemic and pandemic vaccines"
        },
        {
            "endOffset": 19115,
            "parents": [],
            "secId": "s0005",
            "sentence": "The role of DCVMN manufacturers in vaccine supply is illustrated in Figure 1.",
            "startOffset": 19038,
            "title": "Introduction"
        },
        {
            "endOffset": 20927,
            "parents": [],
            "secId": "s0010",
            "sentence": "For bivalent oral poliovirus vaccine (bOPV) in 2017, a rolling buffer of 150 million doses is maintained, with a further 115 million doses of bulk maintained by manufacturers, ready for delivery within 3 months.",
            "startOffset": 20716,
            "title": "Vaccine procurement and financing"
        },
        {
            "endOffset": 22042,
            "parents": [],
            "secId": "s0010",
            "sentence": "There is also a pipeline of Sabin IPV vaccines at the Wuhan site, Sinovac and Minhai Biotechnology.",
            "startOffset": 21943,
            "title": "Vaccine procurement and financing"
        },
        {
            "endOffset": 37574,
            "parents": [],
            "secId": "s0035",
            "sentence": "Packaging technologies, such as cartridges are being developed by Duoject/PnuVax, for PCV-13 application.",
            "startOffset": 37469,
            "title": "Innovative solutions for vaccine supply and distribution"
        },
        {
            "endOffset": 21555,
            "parents": [],
            "secId": "s0010",
            "sentence": "Development of Sabin IPV is progressing and a bulk stockpile of monovalent OPV type 2 is being established in collaboration with the GPEI.",
            "startOffset": 21417,
            "title": "Vaccine procurement and financing"
        }
    ],
    "docId": "S0264410X18306558",
    "metadata": {
        "asjc": [
            "1313",
            "2400",
            "2725",
            "2739",
            "3400"
        ],
        "authors": [
            {
                "email": "s.pagliusi@dcvmn.net",
                "first": "Sonia",
                "initial": "S.",
                "last": "Pagliusi"
            },
            {
                "email": "maureen@qast.co.za",
                "first": "Maureen",
                "initial": "M.",
                "last": "Dennehy"
            },
            {
                "email": "ebolakim@sk.com",
                "first": "Hun",
                "initial": "H.",
                "last": "Kim"
            },
            {
                "email": null,
                "first": null,
                "initial": null,
                "last": null
            }
        ],
        "doi": "10.1016/j.vaccine.2018.05.035",
        "firstpage": "7430",
        "issn": "0264410X",
        "keywords": [
            "Developing countries",
            "Epidemic",
            "Procurement",
            "Stockpiling",
            "Technology",
            "Vaccine manufacturing"
        ],
        "lastpage": "7437",
        "openaccess": "Full",
        "pub_year": 2018,
        "subjareas": [
            "BIOC",
            "IMMU",
            "MEDI",
            "VETE"
        ],
        "title": "Vaccines, inspiring innovation in health"
    }
}